Oncology Generics Demand

Expanding U.S. generic oncology company seeks CTDs or MA-approved products with dossiers and manufacturing supplier that could pass a FDA inspection leading to approvals in U.S. and Europe. Company's strength is in oncology marketing and sales, and FDA regulatory affairs, so we need partners who can reliably supply the U.S. (North American) oncology market. We are looking for "old drugs" such as Doxorubicin, Cisplatin, Daunorubicin, Cytarabine, etc. as well as "new drugs" such as Docetaxel, Oxaliplatin, Gemcitabine, Pemetrexed, Imatinib and others.

We are will to pay up-front fees, approval milestones, and transfer fees.

Contact is: jasinkule@gmail.com or phone is: 1 (480) 427-2026